Curcumin Microcapsule Formulations for Prolong Persistence in the Photodynamic Inactivation of Aedes aegypti Larvae
<b>Background:</b> Viral diseases including dengue, zika, chikungunya, and yellow fever remain a significant public health challenge, primarily due to the increasing resistance of these vectors, the <i>Aedes aegypti</i> mosquito, to conventional control methods. <b>Objectives:</b> Herein, a microencapsulated curcumin formulation was developed and characterized using spray-drying technology, with D-mannitol and starch as encapsulating agents. After microencapsulation, photolarvicidal tablet formulations (Formulated Curcumin Tablets-FCT) were prepared, varying the proportions of starch and pectin: FCT1 (60% starch), FCT2 (35% pectin and 25% starch), and FCT3 (42.5% pectin and 17.5% starch), while maintaining 10% curcumin and 30% D-mannitol in all formulations. The main goal was to enhance the stability and efficacy of curcumin as a photolarvicidal agent. <b>Methods:</b> The formulation was characterized by UV-Vis spectroscopy, confocal microscopy, thermal analysis (TG and DSC), scanning electron microscopy (SEM), fourier transform infrared spectroscopy (FTIR), and photodegradation assays under fluorescent light. <b>Results:</b> The photodynamic inactivation (PDI) of <i>Ae. aegypti</i> larvae was evaluated under white, fluorescent light exposure, and the formulation exhibited a significantly enhanced larvicidal activity compared to free curcumin, with a 57-fold reduction in LC<sub>50</sub> (LC<sub>50-24h</sub> = 0.27 mg/L). Additionally, the most effective formulation, FCT2, maintained its residual activity for 27 days, reinforcing that curcumin microencapsulation, combined with PDI, can extend vector control. Release studies under different pH conditions confirmed a controlled release mechanism, favoring environmental stability. <b>Conclusions:</b> The results indicate that microencapsulated curcumin has great potential as a sustainable photoinsecticidal agent, offering stability, efficacy, and a promising alternative for managing <i>Ae. aegypti</i> larval populations.
Authors
- Francisco Eduardo Gontijo Guimarães (ORCID: https://orcid.org/0000-0002-2504-7812)
- Natália Mayumi Inada (ORCID: https://orcid.org/0000-0003-1940-186X)
- Alessandra Ramos Lima
- Matheus Garbuio (ORCID: https://orcid.org/0000-0001-9055-205X)
- Edgar Aparecido Sanches (ORCID: https://orcid.org/0000-0002-1446-723X)
- Vanderlei Salvador Bagnato (ORCID: https://orcid.org/0000-0003-4833-239X)
- Hernane da Silva Barud (ORCID: https://orcid.org/0000-0001-9081-2413)
- Larissa Marila de Souza (ORCID: https://orcid.org/0000-0001-7884-2011)
- Lucas D. Dias (ORCID: https://orcid.org/0000-0003-2858-7539)
- Ana Paula da Silva (ORCID: https://orcid.org/0000-0002-5050-6419)
- Jean Carlos Ferreira Machado
Institutions
- Universidade Federal de São Carlos (BR)
- Universidade de São Paulo (BR)
- Universidade Evangelica de Goiás (BR)
- Centro Universitário de Araraquara (BR)
- Universidade Federal do Amazonas (BR)
- Texas A&M University (US)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3390/pharmaceutics17040496
- Citations
- 1
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.59